GO:0050839 cell adhesion molecule binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050839 (cell adhesion molecule binding) is a molecular function defined as binding to a cell adhesion molecule.
• Cell adhesion molecules (CAMs) include immunoglobulin superfamily members such as ICAM-1 and VCAM-1, cadherins, selectins, and integrins, and their binding interactions mediate cell-cell and cell-matrix adhesion.
• CAM binding is central to leukocyte trafficking, inflammation, tissue development, and cancer progression.
• Dysregulated CAM interactions contribute to diseases including inflammatory bowel disease, kidney injury, retinal inflammation, and multiple cancers.
• Surface plasmon resonance (SPR) is a key method for measuring CAM binding affinities and kinetics.
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of CAM binding in disease.
Description
Cell adhesion molecule binding (GO:0050839) is a molecular function that describes the binding of a protein or other molecule to a cell adhesion molecule (CAM). CAMs are cell surface proteins that mediate cell-cell and cell-extracellular matrix interactions, and their binding partners include other CAMs, extracellular matrix components, and signaling receptors. This function is fundamental to tissue architecture, immune cell trafficking, and developmental processes. Researchers study cell adhesion molecule binding to understand how cells physically interact and communicate. For example, the binding of integrin alpha4beta7 to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) directs lymphocyte homing to the gut, and this interaction is a therapeutic target in inflammatory bowel disease. Similarly, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) bind leukocyte integrins to promote inflammation in the kidney and other tissues. Dysregulation of CAM binding is implicated in cancer, where molecules such as CADM1 and CEACAM6 influence tumor progression and viral entry. Understanding the molecular details of these interactions, including affinity and kinetics, is essential for developing targeted therapies and for interpreting functional genomics screens.
cell adhesion molecule binding At A Glance
| GO ID | GO:0050839 |
|---|---|
| GO term | cell adhesion molecule binding |
| Ontology | molecular_function |
| Synonym | adhesive extracellular matrix constituent; CAM binding; cell adhesion molecule activity; cell adhesion receptor activity |
| Major function | Binding to a cell adhesion molecule, mediating cell-cell and cell-matrix interactions. |
| Example molecules | ICAM-1, VCAM-1, MAdCAM-1, CADM1, CEACAM6 |
| Associated processes | Leukocyte adhesion and migration, inflammation, tissue development, cancer progression |
| Research methods | Surface plasmon resonance, CRISPR screens, flow cytometry, immunoassays |
What Is GO:0050839?
In simple terms, cell adhesion molecule binding (GO:0050839) is the activity of physically attaching to a cell adhesion molecule. According to the Gene Ontology, this molecular function is defined as binding to a cell adhesion molecule. It encompasses interactions between CAMs and their ligands, which can be other CAMs, extracellular matrix proteins, or soluble factors. This binding event is a prerequisite for downstream adhesion, signaling, and cellular responses.
Why Is cell adhesion molecule binding Important in Cell Biology?
Cell adhesion molecule binding is essential for multicellular life, as it governs how cells stick to each other and to their surroundings. This function is critical for immune surveillance, wound healing, and organ development, and its dysregulation underlies numerous diseases including inflammatory disorders, cancer, and infections. Understanding the specificity and affinity of CAM binding is therefore a major goal in biomedical research and drug discovery.
• Mediates leukocyte extravasation and homing to tissues during inflammation.
• Contributes to kidney pathology through ICAM-1 and VCAM-1 interactions.
• Involved in retinal endothelial inflammation and leukocyte binding.
• Plays a role in cancer pathogenesis via molecules such as CADM1.
• Serves as a receptor for pathogens like influenza A virus through CEACAM6.
• Provides targets for bispecific antibodies and therapeutic blockade.
• Enables experimental measurement of binding kinetics using SPR.
• Underpins CRISPR screening strategies to identify adhesion regulators.
What Happens During cell adhesion molecule binding?
Ligand recognition and initial contact
In simple terms: The binding partner first recognizes and touches the cell adhesion molecule.
Cell adhesion molecule binding begins with the specific recognition of a CAM by its ligand, which may be another CAM, an integrin, or an extracellular matrix component. For example, the integrin alpha4beta7 binds to MAdCAM-1 through a defined motif, enabling lymphocyte adhesion to mucosal endothelium. This initial contact is often mediated by electrostatic and hydrophobic interactions and can be measured using surface plasmon resonance.
Adhesion strengthening and clustering
In simple terms: After the first contact, multiple bonds form to make the adhesion stronger.
Following initial binding, CAMs and their ligands can cluster on the cell surface, increasing avidity and stabilizing the adhesion. This clustering is observed for ICAM-1 and VCAM-1 on endothelial cells, which engage leukocyte integrins to support firm adhesion under shear stress. The strength and duration of binding are regulated by conformational changes and cytoskeletal interactions.
Signaling and cellular responses
In simple terms: Binding triggers signals inside the cell that change its behavior.
Cell adhesion molecule binding is not merely mechanical; it initiates intracellular signaling cascades that modulate cell survival, proliferation, and migration. For instance, CADM1 binding influences multiple signaling pathways in cancer cells, affecting tumor growth and invasion. Similarly, ICAM-1 engagement on retinal endothelial cells promotes leukocyte binding and inflammatory signaling.
Dynamic regulation and turnover
In simple terms: Adhesions are not permanent; they can be broken and remodeled.
CAM binding is dynamically regulated by changes in expression, post-translational modifications, and proteolytic shedding. For example, transcription factor blockade can reduce ICAM-1 expression and subsequent leukocyte binding in retinal endothelial cells. This dynamic regulation allows cells to adapt adhesion during migration and tissue remodeling.
Key Genes Involved in GO:0050839 cell adhesion molecule binding
The following genes encode proteins that participate in cell adhesion molecule binding, either as CAMs or as their binding partners.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ICAM1 | Intercellular adhesion molecule 1; binds integrins on leukocytes | Inflammation, kidney disease, retinal leukocyte adhesion |
| VCAM1 | Vascular cell adhesion molecule 1; binds alpha4 integrins | Kidney inflammation, leukocyte recruitment |
| MADCAM1 | Mucosal addressin cell adhesion molecule 1; binds alpha4beta7 | Gut lymphocyte homing, colitis models |
| CADM1 | Cell adhesion molecule 1; mediates cell-cell adhesion | Cancer pathogenesis, tumor suppression |
| CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 | Influenza A virus receptor, cancer |
| ITGB7 | Integrin beta 7; partner for MAdCAM-1 | Lymphocyte trafficking, IBD |
| ITGA4 | Integrin alpha 4; forms alpha4beta7 with ITGB7 | Leukocyte adhesion, colitis |
| CDH1 | E-cadherin; calcium-dependent cell-cell adhesion | Epithelial integrity, cancer |
| CDH2 | N-cadherin; mediates neural and mesenchymal adhesion | Development, cancer metastasis |
| CTNNB1 | Beta-catenin; links cadherins to cytoskeleton | Adhesion signaling, cancer |
| SELE | E-selectin; binds sialylated ligands on leukocytes | Inflammation, leukocyte rolling |
| SELP | P-selectin; mediates platelet-leukocyte adhesion | Thrombosis, inflammation |
| ITGAL | Integrin alpha L; partner for ICAM-1 | Leukocyte adhesion, immune response |
| ITGB2 | Integrin beta 2; forms LFA-1 with ITGAL | Leukocyte adhesion deficiency |
| CDH5 | VE-cadherin; endothelial cell-cell adhesion | Vascular permeability, angiogenesis |
| NCAM1 | Neural cell adhesion molecule 1 | Neural development, cancer |
| ALCAM | Activated leukocyte cell adhesion molecule | Immune cell migration, cancer |
| PECAM1 | Platelet endothelial cell adhesion molecule 1 | Endothelial junction, leukocyte transmigration |
How Is cell adhesion molecule binding Regulated?
Cell adhesion molecule binding is regulated at multiple levels, including transcriptional control of CAM expression, post-translational modifications, and conformational changes in integrins. For example, selective transcription factor blockade reduces ICAM-1 expression and leukocyte binding in retinal endothelial cells. In inflammatory bowel disease, the interaction between alpha4beta7 and MAdCAM-1 is modulated by cytokine-induced expression of MAdCAM-1 on endothelial cells. Additionally, binding affinity can be tuned by inside-out signaling that alters integrin conformation.
cell adhesion molecule binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MADCAM1 | Inflammatory bowel disease / colitis | Knockout mouse or human intestinal organoids |
| ICAM1 | Kidney inflammation, retinal leukocyte adhesion | Endothelial cell knockout or overexpression |
| CADM1 | Cancer (various types) | Cancer cell line knockout and xenograft |
| CEACAM6 | Influenza A virus infection, cancer | Knockout or overexpression in epithelial cells |
| CDH1 | Cancer metastasis, epithelial integrity | CRISPR knock-in of point mutations |
Inflammatory and autoimmune diseases
Cell adhesion molecule binding is central to leukocyte recruitment during inflammation. In experimental colitis, the binding of alpha4beta7 to MAdCAM-1 mediates lymphocyte homing to the gut, and blockade of this interaction reduces inflammation. Similarly, ICAM-1 and VCAM-1 binding to integrins contributes to kidney inflammation and injury. In retinal endothelial cells, transcription factor blockade decreases ICAM-1 expression and leukocyte binding, suggesting a therapeutic strategy for ocular inflammation.
Cancer
Altered cell adhesion molecule binding is a hallmark of cancer progression. CADM1, a cell adhesion molecule, has multiple functions in cancer pathogenesis, including tumor suppression and promotion depending on context. CEACAM6, another CAM, acts as a receptor for influenza A virus and is implicated in cancer. Loss of E-cadherin (CDH1) binding leads to epithelial-mesenchymal transition and metastasis.
Infectious diseases
Some pathogens exploit cell adhesion molecule binding for entry. CEACAM6 serves as a protein receptor for influenza A virus, facilitating viral attachment and infection. This highlights the importance of CAM binding in host-pathogen interactions.
From cell adhesion molecule binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ICAM1 reduce leukocyte binding? | ICAM1 knockout endothelial cells |
| Can a point mutation in MADCAM1 abolish alpha4beta7 binding? | MADCAM1 point-mutation knock-in cells |
| Does CADM1 overexpression affect tumor growth? | CADM1 overexpression cancer cell lines |
| What is the binding affinity of CEACAM6 for influenza virus? | CEACAM6 knockout or tagged knock-in cells |
| Does VCAM1 knockdown alter kidney inflammation? | VCAM1 knockout mouse models |
| Can CRISPR screening identify novel CAM binding regulators? | Genome-wide CRISPR knockout library in adhesion assays |
How to Study the cell adhesion molecule binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | Characterizing CAM-ligand interactions |
| Flow cytometry | Cell surface CAM expression | Quantifying ICAM-1 or VCAM-1 levels |
| Static adhesion assay | Cell-cell or cell-matrix adhesion | Testing leukocyte binding to endothelial cells |
| CRISPR knockout screen | Genes required for CAM binding | Identifying novel adhesion regulators |
| Immunoblotting | Protein expression and modifications | Validating CAM expression changes |
| ELISA | Soluble CAM levels | Measuring shed CAMs in disease |
| Immunofluorescence | Subcellular localization of CAMs | Visualizing adhesion structures |
Surface plasmon resonance (SPR)
SPR is a label-free method to measure the binding affinity and kinetics between a CAM and its ligand. It has been used to analyze cell-adhesion molecule interactions in real time.
Flow cytometry and adhesion assays
Flow cytometry can quantify cell surface expression of CAMs, while static or flow-based adhesion assays measure the functional consequence of CAM binding, such as leukocyte adhesion to endothelial cells.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate cell adhesion molecule binding. These screens are powerful for discovering novel CAMs and their regulators.
Immunoassays and immunoblotting
Immunoassays such as ELISA and immunoblotting are used to detect CAM expression and post-translational modifications, providing complementary data to binding assays.
How CRISPR Can Be Used to Study GO:0050839 cell adhesion molecule binding
Knockout
CRISPR knockout of genes encoding CAMs or their ligands can abolish specific binding interactions, enabling loss-of-function studies. For example, ICAM1 knockout in endothelial cells reduces leukocyte binding.
Point Mutation
Point mutations can be introduced to disrupt specific binding motifs, such as the alpha4beta7 binding motif in MAdCAM-1, allowing precise mapping of interaction interfaces.
Knock-in
Knock-in of tagged or reporter versions of CAMs enables tracking of expression and binding in live cells. This is useful for studying dynamic adhesion processes.
Overexpression
Overexpression of a CAM can enhance binding and downstream signaling, providing gain-of-function models to study disease mechanisms such as cancer progression.
How EDITGENE Supports cell adhesion molecule binding Research
Researchers studying cell adhesion molecule binding-related genes often need to determine whether a candidate gene is causally involved in adhesion, inflammation, or cancer. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cell adhesion molecule binding research.
Frequently Asked Questions About cell adhesion molecule binding
What is cell adhesion molecule binding?
Cell adhesion molecule binding (GO:0050839) is a molecular function defined as binding to a cell adhesion molecule, which mediates cell-cell and cell-matrix interactions.
What genes are involved in cell adhesion molecule binding?
Key genes include ICAM1, VCAM1, MADCAM1, CADM1, CEACAM6, and various integrins and cadherins.
What diseases are associated with cell adhesion molecule binding?
Diseases include inflammatory bowel disease, kidney inflammation, retinal inflammation, cancer, and influenza A virus infection.
How is cell adhesion molecule binding measured?
Surface plasmon resonance, flow cytometry, and adhesion assays are commonly used to measure binding affinity and function.
What is the role of ICAM-1 in cell adhesion?
ICAM-1 binds integrins on leukocytes to promote their adhesion to endothelial cells during inflammation.
Can CRISPR be used to study cell adhesion molecule binding?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal studies of CAM function in disease.
What is MAdCAM-1 and its binding partner?
MAdCAM-1 is a mucosal addressin that binds alpha4beta7 integrin to direct lymphocyte homing to the gut.
How does CADM1 function in cancer?
CADM1 has multiple functions in cancer pathogenesis, including roles in cell adhesion and signaling.
Is CEACAM6 a receptor for viruses?
Yes, CEACAM6 acts as a protein receptor for influenza A virus.
What methods are used to study CAM binding kinetics?
Surface plasmon resonance is a key method for analyzing cell-adhesion molecule interactions in real time.
Conclusion
Cell adhesion molecule binding (GO:0050839) is a fundamental molecular function that underlies cell-cell and cell-matrix interactions critical for development, immunity, and tissue homeostasis. Its dysregulation contributes to a wide range of diseases, from inflammatory conditions to cancer and infections. Continued research using advanced methods such as SPR and CRISPR screening will further elucidate the mechanisms and therapeutic potential of CAM binding.
References
- 1. Elangbam CS et al.. 1997. Cell adhesion molecules--update.. Vet Pathol 34(1):61-73 PMID: 9150551
- 2. Fong S et al.. 1997. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Its binding motif for alpha 4 beta 7 and role in experimental colitis.. Immunol Res 16(3):299-311 PMID: 9379078
- 3. Murakami Y et al.. 2025. Multiple Functions of Cell Adhesion Molecule 1 (CADM1) and Its Role in the Pathogenesis of Cancer and Other Diseases.. J Nippon Med Sch 92(2):122-131 PMID: 40399107
- 4. Spiess C et al.. 2015. Alternative molecular formats and therapeutic applications for bispecific antibodies.. Mol Immunol 67(2 Pt A):95-106 PMID: 25637431
- 5. Wuthrich RP. 1992. Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney.. J Am Soc Nephrol 3(6):1201-11 PMID: 1282378
- 6. Ma Y et al.. 2023. Selective Transcription Factor Blockade Reduces Human Retinal Endothelial Cell Expression of Intercellular Adhesion Molecule-1 and Leukocyte Binding.. Int J Mol Sci 24(4) PMID: 36834715
- 7. Rahman SK et al.. 2021. The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus.. Viruses 13(5) PMID: 33919410
- 8. van der Merwe PA et al.. 1996. Analysis of cell-adhesion molecule interactions using surface plasmon resonance.. Curr Opin Immunol 8(2):257-61 PMID: 8725949
